Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer [Phase 2]
Phase II randomized study evaluating palbociclib with letrozole as neoadjuvant therapy in ER-positive primary breast cancer; the trial is co…
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast Cancer [Phase 3]
Phase 3 trial evaluating chidamide in combination with exemestane in advanced breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast Cancer [Phase 2, Phase 3]
Clinical trial evaluating the efficacy and safety of adjuvant docetaxel and trastuzumab in stage I HER2-positive breast cancer across Phase …
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Radiotherapy for Extracranial Oligometastatic Breast Cancer [Phase 3]
Phase 3 clinical trial investigating radiotherapy for extracranial oligometastatic breast cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Aromatase Inhibitor and Durvalumab in Postmenopausal Breast Cancer [Phase 2]
Phase 2 trial of an aromatase inhibitor plus durvalumab in postmenopausal hormone receptor-positive breast cancer has been terminated with r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Is it Feasible?: Self-Affirmation for Hereditary Breast and Ovarian Cancer Genetic Counseling [NA]
A completed clinical trial evaluating the feasibility of self-affirmation in genetic counseling for hereditary breast and ovarian cancer; re…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT) [Phase 1]
Phase 1 trial update for BN-Brachyury, Entinostat, Adotrastuzumab Emtansine, and M7824 in advanced breast cancer; trial status terminated wi…
-
CLINICAL_TRIALS trial_result · 2022-01-05Clinical Trial Update: Exploratory Study of Neoadjuvant Treatment of HER2-positive Breast Cancer With Py in Combination With HP [Phase 4]
Exploratory Phase 4 trial evaluating neoadjuvant treatment of HER2-positive breast cancer with Py in combination with HP.
-
CLINICAL_TRIALS trial_result · 2022-01-04Clinical Trial Update: Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT) [Phase 2]
Phase 2 trial evaluating whether statins prevent doxorubicin-induced cardiovascular toxicity in patients with breast cancer or lymphoma.
-
CLINICAL_TRIALS trial_result · 2022-01-03Clinical Trial Update: Durvalumab (MEDI4736) and Tremelimumab in Hormone Receptor-positive, Hypermutated Metastatic Breast Cancer Identified by Whole Exome Sequencing [Phase 2]
Phase 2 trial evaluating durvalumab and tremelimumab in hormone receptor-positive, hypermutated metastatic breast cancer identified by whole…
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors [Phase 2]
Phase 2 trial evaluating docosahexaenoic acid (DHA) in breast cancer survivors has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer [Phase 2]
Phase II study of nivolumab plus cabozantinib for metastatic triple-negative breast cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2021-12-21Clinical Trial Update: Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole [Phase 3]
Phase 3 trial evaluating delayed versus immediate use of zoledronic acid in postmenopausal early breast cancer patients on adjuvant letrozol…
-
CLINICAL_TRIALS trial_result · 2021-12-20Clinical Trial Update: Capecitabine in Metastatic Breast and GI Cancers [Phase 2]
Phase 2 clinical trial update for capecitabine in metastatic breast and gastrointestinal cancers.
-
CLINICAL_TRIALS trial_result · 2021-12-20Clinical Trial Update: Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating dHER2+ AS15 cancer vaccine in combination with lapatinib for metastatic breast cancer has completed wi…
-
CLINICAL_TRIALS trial_result · 2021-12-17Clinical Trial Update: Single Fraction Elderly Breast Irradiation (SiFEBI) [NA]
A completed clinical trial (SiFEBI) studying single-fraction elderly breast irradiation for breast cancer; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: Neratinib Dose Escalation Regimen for HER2 Positive Early Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating a neratinib dose escalation regimen for HER2-positive breast cancer.
-
FDA approval · 2021-12-10FDA Approved: KISQALI FEMARA CO-PACK — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application to approve a co-packaged formulation of KISQALI (ribociclib) with FEMARA (letrozole), enabling their…
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer [Phase 3]
This update reports results from a Phase 3 trial of olaparib as adjuvant treatment in germline BRCA-mutated high-risk HER2-negative primary …
-
CLINICAL_TRIALS trial_result · 2021-12-07Clinical Trial Update: Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer [Phase 2]
Phase 2 randomized trial evaluating neoadjuvant chemotherapy with or without metformin for HER2-positive operable breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-12-07Clinical Trial Update: Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment [Phase 2]
Phase 2 clinical trial evaluating metformin as adjuvant therapy for metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-12-02Clinical Trial Update: Axillary Sentinel or Targeted Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy in Node-positive Breast Cancer [Phase 2]
Phase 2 trial update evaluating axillary sentinel or targeted lymph node biopsy alone after neoadjuvant chemotherapy in node-positive breast…
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Participants With Advanced Breast Cancer [Phase 2]
Phase 2 trial comparing eribulin mesylate versus ixabepilone in causing or worsening neuropathy in advanced breast cancer; results completed…
-
CLINICAL_TRIALS trial_result · 2021-11-29Clinical Trial Update: Comparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study) [Phase 3]
A Phase 3 comparative study evaluating scalp cooling system versus chemical cold cap for primary breast cancer is ongoing, with status curre…
-
CLINICAL_TRIALS trial_result · 2021-11-29Clinical Trial Update: Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy [Phase 3]
Phase 3 trial update on alternative non-cross-resistant adjuvant chemotherapy for operable breast cancer showing primary chemotherapy non-re…